Basics Atea Pharmaceuticals, Inc. IPO Date: October 30, 2020 Sector: Healthcare Industry: Biotech Market Cap: $252.46M Activated in VL: True Average Daily Range Avg Daily Range: $0.44 | 2.73% Avg Daily Range (30 D): $0.08 | 2.83% Avg Daily Range (90 D): $0.07 | 2.43% Institutional Daily Volume Avg Daily Volume: .72M Avg Daily Volume (30 D): .43M Avg Daily Volume (90 D): .32M Trade Size Avg Trade Size (Sh.): 120 Avg Trade Size (Sh.) (30 D): 136 Avg Trade Size (Sh.) (90 D): 129 Institutional Trades Total Inst.Trades: 740 Avg Inst. Trade: $1.97M Avg Inst. Trade (30 D): $.91M Avg Inst. Trade (90 D): $.8M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.58M Avg Closing Trade (30 D): $.56M Avg Closing Trade (90 D): $.56M Avg Closing Volume: 182.87K         News Apr 23, 2025 @ 11:00 AM Atea Pharmaceuticals to Present New Data Showcasin... Source: N/A Apr 9, 2025 @ 11:00 AM Atea Pharmaceuticals Announces Dosing of First Pat... Source: N/A Mar 26, 2025 @ 5:58 PM Atea Pharmaceuticals Highlights Actions Underway t... Source: N/A Mar 21, 2025 @ 9:54 PM Atea Pharmaceuticals Issues Statement Regarding Di... Source: N/A Mar 19, 2025 @ 11:00 AM Atea Pharmaceuticals Announces Presentation of Bem... Source: Atea Pharmaceuticals Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.65 $-.4 $-.4 Diluted EPS $-1.65 $-.4 $-.4 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -139.49M $ -34.27M $ -33.54M Operating Income / Loss $ -162.19M $ -39.04M $ -39.03M Cost of Revenue $ $ $ Net Cash Flow $ -41.52M $ 54.7M $ -33.77M PE Ratio     Splits Feb 14, 2018:   1:11